Articles tagged with Antibiotics
Bacteria have been found to use a code language consisting of cryptic palindromes to determine whether to enter a dormant state or be interrupted by antibiotics. This discovery may help develop new antibiotics by understanding the code language used by pathogenic bacteria.
A study published in mBio found that fecal microbiota transplantation was effective in treating recurrent C. difficile infection, with cure rates over 90%. The researchers identified specific microorganisms, such as Clostridium Xia clade and Holdemania, which are key for a successful transplant.
Scientists have discovered molecular mechanisms that allow bacteria to survive antibiotic treatment and cause chronic infections. These 'persister cells' can resuscitate after treatment is abandoned, leading to relapsing infections. Understanding this phenomenon may lead to the development of novel antibiotics targeting persisters.
A team of UCLA researchers has developed an automated diagnostic test reader for antimicrobial resistance using a smartphone. The device connects to a phone and conducts testing on up to 96 wells, with results returned in under one minute.
Researchers developed antibacterial agents using usnic acid-loaded electrospun fibers, which showed controlled release and mass production of active surface. The fibers demonstrated effective bactericidal activity against different bacteria, making them a promising secondary therapy for diabetic wound healing treatment.
Researchers discovered a bacterium in Lechuguilla Cave that resists 18 different antibiotics, including 'drugs of last resort'. This finding suggests evolutionary pressure has driven resistance for millions of years, not just since antibiotics were introduced.
Researchers developed electrospun fibers loaded with usnic acid, a strong lichen metabolite, to combat bacterial infections. The fibers show controlled release properties and mass production potential for antibacterial materials.
Researchers at Ludwig-Maximilians-Universität München discovered a mechanism to recycle bacterial ribosomes stalled on messenger RNAs lacking termination codons. This process, involving the protein ArfA, has emerged as a promising target for developing new antibiotics.
The American College of Physicians survey found that internists frequently prescribe high-cost treatments with little benefit to patients. Despite guidelines recommending against these practices, many physicians continue to use them, reflecting a desire to err on the side of treatment.
Bacteria carrying a transmissible carbapenem resistance gene have been detected in US farm animals, posing a risk to public health. The finding highlights the need for monitoring farms and re-examining agricultural practices that may be contributing to antibiotic resistance.
A recent study reveals that syphilis has re-emerged globally, primarily caused by a pandemic strain cluster named SS14-Ω. This cluster exhibits high levels of antibiotic resistance, particularly to azithromycin, posing a significant public health concern. The researchers hope that their findings will contribute to a better understandin...
A Melbourne-based team has developed a vaccine for chronic periodontitis, aiming to reduce the need for surgery and antibiotics. The vaccine targets enzymes produced by a specific bacterium, triggering an immune response that neutralizes its toxins.
French researchers have discovered that Streptomyces bacteria can be used as an environmentally friendly alternative to pesticides. The bacteria promotes plant growth and controls pests in the soil. This study could lead to sustainable agricultural practices and reduce harm to human health and the environment.
A national study led by Baylor College of Medicine aims to understand the link between antibiotic use and improvements in autism symptoms in some children. The research, funded by N of One: Autism Research Foundation, will examine the gut microbiome and metabolome for two years to identify potential causes and effects.
Russian scientists have developed a new technique for antibiotic efficiency testing, which measures antimicrobial activity and determines the mode of action. The system allows for the analysis of thousands of compounds per day and provides insights into the efficacy of new germicides.
Scientists at NC State University have discovered a way to make pinpoint changes to an enzyme-driven assembly line that will enable the creation of new antibiotics with desired properties. By tweaking the function of individual modules in the enzyme, researchers can design man-made molecules with precise control.
A WSU research team has successfully used a mild electric current to kill drug-resistant bacterial infections, including Pseudomonas aeruginosa PAO1, responsible for chronic and serious infections in lung diseases and wounds. The technology uses an antibiotic in combination with the electric current to disrupt biofilm matrices, damage ...
Researchers are conducting a clinical trial to assess whether a shorter course of antibiotics can effectively treat community-acquired pneumonia (CAP) in young children. The study aims to reduce the need for longer antibiotic treatments and conserve the long-term effectiveness of available drugs.
A study found that adverse drug events in the US resulted in an estimated 4 ED visits per 1,000 individuals annually in 2013-2014. Anticoagulants and diabetes agents were implicated in 47% of these events, with older adults experiencing higher hospitalization rates.
Researchers developed a new method to identify antibiotics hidden in massive mass spectrometry datasets. By running data against a database of known antibiotics, they detected previously unknown compounds and discovered new variants of existing ones. This breakthrough aims to help combat antibiotic resistance.
Researchers have found worrying traces of resistant bacteria in the air, which could lead to the development of last-resort antibiotic-resistant infections. The study analyzed DNA from humans, animals, and environments worldwide and found a wide mix of resistance genes, including those that make bacteria resistant to carbapenems.
Antibiotic resistance increased across Europe in 2015, with EU-wide carbapenem resistance in Klebsiella pneumoniae rising to 8.1%. Prudent use of antibiotics is crucial to prevent the spread of resistant bacteria. The European Commission will launch a new action plan to tackle antibiotic resistance.
A study published in Pediatrics found that oral antibiotics are as effective as intravenous therapy in managing residual disease in children with complex pneumonia. This approach avoids the risk of infection and medical complications associated with PICC lines, providing a safer care option for families.
Researchers at the University of Oklahoma have identified four new chemicals that disrupt bacterial proteins called efflux pumps, a major cause of antibiotic resistance. These molecules could drastically reduce the time needed to move from experimental phase to clinical trials.
A new clinical trial aims to determine if a rapid molecular diagnostic test can identify gonorrhea infections successfully treated with a single dose of ciprofloxacin. The study will enroll up to 381 participants and may provide a reliable marker for treating gonorrhea with this older antibiotic.
Highly drug-resistant Pseudomonas aeruginosa infections are on the rise among US children, with increasing antibiotic resistance rates reported over the last decade. The study highlights the need for better tracking and prevention strategies to address these concerning infections.
Researchers at Rockefeller University have discovered two promising new antibiotics, humimycin A and humimycin B, produced by bacteria in the human body. The compounds work by inhibiting an enzyme that builds bacterial cell walls, offering a potential solution to antibiotic resistance.
Surgeons must take a leadership role in promoting antimicrobial stewardship to address the urgent problem of antibiotic overuse. The World Society of emergency Surgery and the Surgical Infection Society have issued a call to action, urging surgeons to standardize antibiotic use and support multidisciplinary collaborations.
Researchers have identified a new treatment strategy for MRSA infections that uses a combination of modern-day antibiotics and old-fashioned penicillin to weaken the virulence of the bacteria. This approach has shown promising results in reducing the duration of MRSA sepsis from 3 days to 1.9 days.
Researchers at LA BioMed have discovered a low-cost eye drop solution that is equally effective to expensive antibiotics in treating bacterial keratitis. The povidone-iodine solution has the potential to save thousands of lives by preventing blindness in developing countries.
A new generation of teixobactin-based antibacterial drugs has been discovered by HKU Chemists. The researchers successfully synthesized the antibiotic Teixobactin, which can kill a range of pathogens without detectable resistance.
Researchers found that genetic background affects response to antibiotics on gut microbiome, insulin sensitivity, tissue inflammation, and metabolic functions in mice. This study suggests that genetic susceptibility plays a role in predicting the usefulness of microbiome therapies for obesity and metabolic disease.
A new study found that misdiagnosis of cellulitis leads to significant healthcare costs, with estimates suggesting between 50,000 and 130,000 unnecessary hospitalizations. The study also reveals that misdiagnosed patients would not have required antibiotics or prolonged hospital stays if they had been diagnosed correctly.
Researchers have engineered a new antimicrobial peptide that can destroy many types of bacteria, including those resistant to most antibiotics. The peptide also suppresses the overactive inflammatory response and destroys biofilms, making it a promising alternative for treating infections.
Researchers found that chloramphenicol and linezolid attack the catalytic center of the ribosome, but stop protein synthesis only at specific checkpoints. This new understanding could lead to better drugs and more efficient treatment of human and animal diseases.
A study of over 260,000 infants found that untreated infections during infancy increased the risk of childhood obesity by 25%. The research suggests that reducing infant infections may be a key strategy for preventing childhood obesity.
A new study from the University of Chicago Medicine found that social media platforms can effectively inform young physicians about proper antibiotic use, improving their knowledge and behavior. The strategy successfully directed medical residents to relevant clinical pathways, resulting in a significant increase in correct usage.
A first-of-its-kind study of 900,000 hospital admissions found a significant increase in ESBL positive organisms (322%) and C. difficile cases (222%), while MRSA rates decreased by 32%. The study highlights the need for new diagnostic tests to address the growing threat of antibiotic-resistant bacteria.
Scientists have developed a new class of small molecules that prevent bacteria from causing urinary tract infections by interfering with a critical factor on the surface of UTI-causing bacteria. The treatment, called C-mannosides, has shown promising results in animal testing and may move to clinical trials.
Scientists at Imperial College London discovered that MRSA releases decoy molecules to escape being killed by daptomycin. The decoys are made of the same type of fat as MRSA cells and allow the bacteria to evade destruction. Further experiments showed that a second antibiotic, oxacillin, can partially prevent decoy release.
A team of researchers has successfully developed liquid-crystalline nanostructures that protect antimicrobial peptides, allowing them to target and destroy bacteria without being degraded. This innovative approach could provide a new weapon in the fight against antibiotic-resistant superbugs.
Researchers have revealed the bilayer properties of 21 distinct Lipid A types from 12 Gram-negative bacterial species through biomolecular systems simulation. This study provides crucial information for developing new antibiotics against 'bad bugs' like superbugs, with the goal of accelerating drug development and improving treatment o...
A new study from Intermountain Medical Center found that antibiotic use rates in small community hospitals are similar to those in large hospitals. The lack of antimicrobial stewardship programs in smaller facilities poses a significant challenge in addressing the growing problem of antibiotic-resistant bacteria.
Researchers found that the patient's intestinal microbiota resembled the donor's microbiota and remained stable throughout a 1-year follow-up period. The study suggests that intestinal microbiota can be modified relatively permanently, paving the way for bacteriotherapy products.
A study found that using the same hospital bed as a prior patient who received antibiotics increases the risk of Clostridium infection in subsequent patients. The risk was 0.72% when the prior occupant had recently used antibiotics, compared to 0.43% when they hadn't.
A team of researchers has unraveled the mechanism of a key enzyme involved in bacterial antibiotic resistance. The study, published in the Journal of Biological Chemistry and PLOS One, reveals the structure of Rifampicin monooxygenase and provides detailed information on its mechanism of action.
A US university is testing an intervention to reduce antibiotic prescriptions for viral infections, a major contributor to antibiotic resistance. The study focuses on adult acute bronchitis and children's upper respiratory tract infections, aiming to promote better use of antibiotics and reduce resistance.
A study found that disease-causing gut bacteria, Enteroaggregative E. coli, are prevalent in 14% of children, even in industrialized countries with mild symptoms. The researchers hope to investigate factors contributing to diarrheal disease and explore probiotic agents for maintaining gut balance.
A randomized trial found no significant differences in rates of complications between observation and antibiotic treatment groups for uncomplicated diverticulitis. Patients who received antibiotics had shorter hospital stays compared to those who underwent observation.
A recent UCLA-led study found that nearly 12% of people diagnosed with pyelonephritis had antibiotic-resistant infections, up from 4% a decade ago. The emergence of ESBL-producing E. coli strains limits treatment options, highlighting the need for new medications and guidelines.
Scientists discovered that a common intestinal microbe produces an enzyme called SagA, which protects worms and mammals from harmful bacteria like Salmonella typhimurium. The findings could lead to the development of probiotics against Clostridium difficile, a leading cause of hospital-acquired infections.
A new study reveals that bacteria can evolve resistance to antibiotics by adapting to intermediate concentrations, and that spatial location plays a role in their success. Mutations that increased resistance often came at the cost of reduced growth, which was subsequently restored by additional compensatory mutations.
Researchers created a device called MEGA plate to observe bacteria adapting to increasing antibiotic doses, revealing key insights into the spread of resistance. The study provides a powerful visualization of bacterial movement and evolution.
Dr. Richard Rosenfeld suggests a pragmatic approach to diagnosing and treating bacterial sinus infections in adults, emphasizing symptomatic treatment over antibiotics. The recommended 'watchful waiting' approach involves monitoring symptoms and reserving antibiotics for worsening cases.
Researchers have discovered a connection between antimicrobial chemicals and antibiotic-resistance genes in indoor dust. The study, conducted by the University of Oregon, found six strong associations between triclosan levels and antibiotic-resistance genes.
Researchers found that a repurposed drug, pirfenidone, increased lung lesions and prevented antibiotics from targeting TB bacteria. The study suggests caution when using host-directed therapies for TB, emphasizing the need for careful vetting of new treatments.
Research reveals that early exposure to antibiotics is associated with a higher risk of developing eczema and hay fever. The study found that the use of antibiotics in early childhood can lead to a stronger immune response, disrupting the balance of gut microbiome.
Research from the University of South Carolina suggests that antibiotic treatment within the first year of life may increase food allergy diagnosis in children. The study analyzed data from 2007 to 2009 and found a strong association between antibiotic prescription and development of food allergies.
A new study identified seven key predictors that can help doctors identify low-risk children who are less likely to need antibiotics. The proposed tool, STARWAVe, uses these predictors to estimate a child's risk of future hospitalization and provides guidance for antibiotic prescribing.
A Rochester Institute of Technology professor has received a $436,989 grant to study the efficacy of using the DapL enzyme in creating narrow-spectrum antibiotics. The research could lead to breakthroughs in targeting pathogenic bacteria and help combat the growing threat of antibiotic-resistant bacteria.